1. Home
  2. FMAO vs RZLT Comparison

FMAO vs RZLT Comparison

Compare FMAO & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmers & Merchants Bancorp Inc.

FMAO

Farmers & Merchants Bancorp Inc.

HOLD

Current Price

$35.00

Market Cap

474.2M

Sector

Finance

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$4.74

Market Cap

420.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMAO
RZLT
Founded
1897
2010
Country
United States
United States
Employees
473
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
474.2M
420.8M
IPO Year
1996
2011

Fundamental Metrics

Financial Performance
Metric
FMAO
RZLT
Price
$35.00
$4.74
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$28.50
$9.67
AVG Volume (30 Days)
70.3K
1.6M
Earning Date
04-22-2026
05-13-2026
Dividend Yield
3.45%
N/A
EPS Growth
27.89
26.32
EPS
0.70
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.20
N/A
P/E Ratio
$49.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.89
$1.07
52 Week High
$34.74
$11.46

Technical Indicators

Market Signals
Indicator
FMAO
RZLT
Relative Strength Index (RSI) 77.74 50.61
Support Level $26.09 $2.91
Resistance Level N/A $5.42
Average True Range (ATR) 1.47 0.34
MACD 0.37 -0.03
Stochastic Oscillator 92.03 51.39

Price Performance

Historical Comparison
FMAO
RZLT

About FMAO Farmers & Merchants Bancorp Inc.

Farmers & Merchants Bancorp Inc is a holding company based in Ohio. The company is engaged in one segment which is commercial banking. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: